NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.21
(3.37%)
CNY 5.21
(3.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.24 Billion CNY | 181.64% |
| 2022 | 3.28 Billion CNY | -25.51% |
| 2021 | 4.4 Billion CNY | -5.53% |
| 2020 | 4.66 Billion CNY | 339.57% |
| 2019 | 1.06 Billion CNY | 37.2% |
| 2018 | 773.48 Million CNY | -76.4% |
| 2017 | 3.27 Billion CNY | 486.26% |
| 2016 | 559.12 Million CNY | 15.41% |
| 2015 | 484.46 Million CNY | -70.33% |
| 2014 | 1.63 Billion CNY | -10.8% |
| 2013 | 1.83 Billion CNY | 295.93% |
| 2012 | 462.28 Million CNY | -51.85% |
| 2011 | 960.15 Million CNY | 385.97% |
| 2010 | 197.57 Million CNY | -66.29% |
| 2009 | 586.03 Million CNY | 47.94% |
| 2008 | 396.12 Million CNY | 354.37% |
| 2007 | 87.18 Million CNY | -60.24% |
| 2006 | 219.25 Million CNY | -43.42% |
| 2005 | 387.54 Million CNY | -30.86% |
| 2004 | 560.51 Million CNY | 5.51% |
| 2003 | 531.23 Million CNY | 92.1% |
| 2002 | 276.54 Million CNY | 41.08% |
| 2001 | 196.02 Million CNY | -6.05% |
| 2000 | 208.64 Million CNY | 436.42% |
| 1999 | 38.89 Million CNY | 1325.79% |
| 1998 | -3.17 Million CNY | -106.17% |
| 1997 | 51.44 Million CNY | 280.29% |
| 1996 | -28.53 Million CNY | -137.14% |
| 1995 | 76.83 Million CNY | 36.41% |
| 1994 | 56.32 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 11.38 Billion CNY | 23.15% |
| 2024 Q2 | 8.06 Billion CNY | -29.12% |
| 2024 Q3 | 10.97 Billion CNY | 36.05% |
| 2023 Q1 | 7.01 Billion CNY | 113.76% |
| 2023 Q4 | 9.24 Billion CNY | 31.49% |
| 2023 Q3 | 7.03 Billion CNY | 2.57% |
| 2023 Q2 | 6.85 Billion CNY | -2.31% |
| 2023 FY | 9.24 Billion CNY | 181.64% |
| 2022 Q3 | 5.72 Billion CNY | 1.41% |
| 2022 Q1 | 4.63 Billion CNY | 5.09% |
| 2022 FY | 3.28 Billion CNY | -25.51% |
| 2022 Q4 | 3.28 Billion CNY | -42.66% |
| 2022 Q2 | 5.64 Billion CNY | 21.89% |
| 2021 Q2 | 5.81 Billion CNY | -3.75% |
| 2021 Q1 | 6.03 Billion CNY | 29.42% |
| 2021 FY | 4.4 Billion CNY | -5.53% |
| 2021 Q4 | 4.4 Billion CNY | -23.13% |
| 2021 Q3 | 5.73 Billion CNY | -1.35% |
| 2020 FY | 4.66 Billion CNY | 339.57% |
| 2020 Q1 | 2.96 Billion CNY | 179.54% |
| 2020 Q2 | 4.58 Billion CNY | 54.67% |
| 2020 Q3 | 5.17 Billion CNY | 12.87% |
| 2020 Q4 | 4.66 Billion CNY | -9.92% |
| 2019 Q2 | 3.29 Billion CNY | 146.75% |
| 2019 Q4 | 1.06 Billion CNY | -68.76% |
| 2019 Q3 | 3.39 Billion CNY | 3.22% |
| 2019 Q1 | 1.33 Billion CNY | 72.43% |
| 2019 FY | 1.06 Billion CNY | 37.2% |
| 2018 Q3 | 2.45 Billion CNY | -16.74% |
| 2018 FY | 773.48 Million CNY | -76.4% |
| 2018 Q4 | 773.48 Million CNY | -68.44% |
| 2018 Q2 | 2.94 Billion CNY | -8.43% |
| 2018 Q1 | 3.21 Billion CNY | -1.95% |
| 2017 Q4 | 3.27 Billion CNY | -6.9% |
| 2017 FY | 3.27 Billion CNY | 486.26% |
| 2017 Q3 | 3.52 Billion CNY | 20.02% |
| 2017 Q2 | 2.93 Billion CNY | 39.87% |
| 2017 Q1 | 2.09 Billion CNY | 275.08% |
| 2016 Q1 | 477.57 Million CNY | -1.42% |
| 2016 Q3 | -279.5 Million CNY | -168.25% |
| 2016 FY | 559.12 Million CNY | 15.41% |
| 2016 Q2 | 409.49 Million CNY | -14.25% |
| 2016 Q4 | 559.12 Million CNY | 300.04% |
| 2015 Q2 | 1.08 Billion CNY | -42.41% |
| 2015 Q1 | 1.88 Billion CNY | 15.74% |
| 2015 Q3 | 1.1 Billion CNY | 1.16% |
| 2015 Q4 | 484.46 Million CNY | -55.99% |
| 2015 FY | 484.46 Million CNY | -70.33% |
| 2014 FY | 1.63 Billion CNY | -10.8% |
| 2014 Q1 | 2.11 Billion CNY | 15.61% |
| 2014 Q2 | 1.68 Billion CNY | -20.32% |
| 2014 Q3 | 1.83 Billion CNY | 8.65% |
| 2014 Q4 | 1.63 Billion CNY | -10.87% |
| 2013 Q1 | 1.15 Billion CNY | 149.75% |
| 2013 Q2 | 1.67 Billion CNY | 45.05% |
| 2013 Q3 | 1.74 Billion CNY | 4.01% |
| 2013 Q4 | 1.83 Billion CNY | 5.08% |
| 2013 FY | 1.83 Billion CNY | 295.93% |
| 2012 Q2 | 866.52 Million CNY | 49.5% |
| 2012 Q3 | 1.2 Billion CNY | 39.15% |
| 2012 Q4 | 462.28 Million CNY | -61.66% |
| 2012 FY | 462.28 Million CNY | -51.85% |
| 2012 Q1 | 579.61 Million CNY | -39.63% |
| 2011 Q2 | -65.2 Million CNY | -81.41% |
| 2011 Q4 | 960.15 Million CNY | 143.2% |
| 2011 Q3 | 394.8 Million CNY | 705.51% |
| 2011 Q1 | -35.94 Million CNY | -118.19% |
| 2011 FY | 960.15 Million CNY | 385.97% |
| 2010 FY | 197.57 Million CNY | -66.29% |
| 2010 Q4 | 197.57 Million CNY | -63.03% |
| 2010 Q1 | 786.65 Million CNY | 34.23% |
| 2010 Q3 | 534.49 Million CNY | 176.34% |
| 2010 Q2 | 193.41 Million CNY | -75.41% |
| 2009 Q2 | 59 Million CNY | -54.75% |
| 2009 FY | 586.03 Million CNY | 47.94% |
| 2009 Q4 | 586.03 Million CNY | 17.82% |
| 2009 Q1 | 130.38 Million CNY | -67.09% |
| 2009 Q3 | 497.39 Million CNY | 743.02% |
| 2008 Q1 | 204.39 Million CNY | 134.45% |
| 2008 Q2 | 208.73 Million CNY | 2.12% |
| 2008 FY | 396.12 Million CNY | 354.37% |
| 2008 Q3 | 383.09 Million CNY | 83.53% |
| 2008 Q4 | 396.12 Million CNY | 3.4% |
| 2007 Q4 | 87.18 Million CNY | 273.3% |
| 2007 Q3 | 23.35 Million CNY | -92.13% |
| 2007 Q2 | 296.84 Million CNY | -21.63% |
| 2007 Q1 | 378.77 Million CNY | 72.75% |
| 2007 FY | 87.18 Million CNY | -60.24% |
| 2006 FY | 219.25 Million CNY | -43.42% |
| 2006 Q1 | 314.19 Million CNY | -18.93% |
| 2006 Q2 | 404.04 Million CNY | 28.6% |
| 2006 Q3 | 406.47 Million CNY | 0.6% |
| 2006 Q4 | 219.25 Million CNY | -46.06% |
| 2005 FY | 387.54 Million CNY | -30.86% |
| 2005 Q4 | 387.54 Million CNY | -28.64% |
| 2005 Q3 | 543.09 Million CNY | -0.72% |
| 2005 Q2 | 547.01 Million CNY | -6.63% |
| 2005 Q1 | 585.83 Million CNY | 4.52% |
| 2004 Q1 | 508.32 Million CNY | -4.31% |
| 2004 Q2 | 582.24 Million CNY | 14.54% |
| 2004 Q3 | 594.58 Million CNY | 2.12% |
| 2004 FY | 560.51 Million CNY | 5.51% |
| 2004 Q4 | 560.51 Million CNY | -5.73% |
| 2003 Q2 | 465.4 Million CNY | 43.93% |
| 2003 FY | 531.23 Million CNY | 92.1% |
| 2003 Q4 | 531.23 Million CNY | 5.43% |
| 2003 Q3 | 503.89 Million CNY | 8.27% |
| 2003 Q1 | 323.35 Million CNY | 16.92% |
| 2002 FY | 276.54 Million CNY | 41.08% |
| 2002 Q1 | 225.1 Million CNY | 14.84% |
| 2002 Q2 | 233.76 Million CNY | 3.85% |
| 2002 Q3 | 273.62 Million CNY | 17.05% |
| 2002 Q4 | 276.54 Million CNY | 1.07% |
| 2001 Q4 | 196.02 Million CNY | 0.0% |
| 2001 Q2 | 190.28 Million CNY | 0.0% |
| 2001 FY | 196.02 Million CNY | -6.05% |
| 2000 Q4 | 208.64 Million CNY | 0.0% |
| 2000 FY | 208.64 Million CNY | 436.42% |
| 2000 Q2 | 224.21 Million CNY | 0.0% |
| 1999 Q2 | 31.17 Million CNY | 0.0% |
| 1999 Q4 | 38.89 Million CNY | 0.0% |
| 1999 FY | 38.89 Million CNY | 1325.79% |
| 1998 Q2 | -41.53 Million CNY | 0.0% |
| 1998 FY | -3.17 Million CNY | -106.17% |
| 1998 Q4 | -3.17 Million CNY | 0.0% |
| 1997 FY | 51.44 Million CNY | 280.29% |
| 1997 Q4 | 51.44 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | -28.53 Million CNY | 0.0% |
| 1996 FY | -28.53 Million CNY | -137.14% |
| 1995 Q4 | 76.83 Million CNY | 0.0% |
| 1995 FY | 76.83 Million CNY | 36.41% |
| 1994 FY | 56.32 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 144.724% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | -3625.53% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | 702.703% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | 3087.767% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | 3780.739% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | -54916.842% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | -28261.864% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | 1068.864% |